DINETIC AG

Legal notice

Website operator

Dinetic AG
Imfangring 9
6005 Luzern, Switzerland
Commercial Register No.: CH-100.3.811.303-0
UID/VAT No.: CHE-471.683.354
Represented by the management of Dinetic AG
info@dinetic.ch

Purpose and scope

This website provides general information about Dinetic AG, its research and development activities, technologies, products and commercial plans. It does not provide medical advice, a diagnosis or a treatment recommendation. Research results apply to the systems, methods and conditions described. Product and development information may change as testing, production and regulatory work progress.

Investment information

Nothing on this website constitutes a public offer, investment recommendation or financial advice under the Swiss Financial Services Act or comparable international rules. Forward-looking statements reflect current plans and assessments. Actual scientific, regulatory and commercial outcomes may differ because they involve risks and uncertainties.

Accuracy and liability

Dinetic prepares the content with care but does not warrant that it is complete, correct or current at all times. To the extent permitted by law, Dinetic excludes liability for direct or indirect loss arising from access to, use of or inability to use this website, including technical faults or data loss. Dinetic may change or remove content without notice.

External links

Links to third-party websites are provided for convenience. Dinetic does not control their content or data processing and accepts no responsibility for them. Access is at the visitor’s own discretion.

Copyright, trademarks and illustrations

Unless stated otherwise, texts, images, animations, designs and other content are owned by Dinetic AG or used with permission. Use beyond the limits allowed by law requires prior written consent. Fraktion8 and Formula51 are registered trademarks in Switzerland. Scientific illustrations are conceptual and are not microscopy, molecular structure diagrams or experimental evidence. Product images may show pre-production packaging.

Technology status

Fraktion8 has been incorporated into a nanoemulsion. Biological testing of Fraktion8 and the combined nanoemulsion system is ongoing. Formula51 Shield is production-ready but has not yet been produced for sale. Patent documentation has been prepared but no patent application has been filed. These statements describe the status as of the date below and do not promise a particular outcome.

Last updated: 9 September 2026.